Sinovac has already shipped some 380 mn doses, more than AstraZeneca and second only to Pfizer, worldwide. But it still hasn’t published any data in an academic journal.
Indonesia tracked 25,374 health workers in Jakarta for 28 days after receiving their second dose. Health Minister Budi Gunadi said 94% of them had been vaccinated.
Demand is expected to rise if WHO authorises China’s Sinovac & Sinopharm vaccines, allowing developing countries in Asia, Africa & Latin America to access them through Covax.
Vastly different efficacy rates in 4 clinical trial sites raised concerns over whether Sinovac, that’s key to vaccine drives in some of the world's hotspots, will be effective.
The vaccine was found to be about 65% effective against Covid in late stage-trials in the city of Bandung. The emergency use approval is the first for Sinovac’s shot outside of China.
The protection rate, confirmed by Sao Paulo state officials, was derived from Sinovac’s most advanced final-phase trials in Brazil involving about 13,000 participants.
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.
COMMENTS